qs21
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 5, 2021 (NCT04784767)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06741072 | Phase 1 | Jul 1, 2025 | Ohio State University |
| NCT04784767 | Phase 1 | Apr 5, 2021 | Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Army |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Henry M. Jackson Foundation for the Advancement of Military Medicine | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Ohio State University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| United States Army | Government | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1